References
- Konno A, Yamakoshi T, Terada N, Fujita Y. Mode of action of a topical steroid on immediate phase reaction after antigen challenge and non‐specific nasal hyperreactivity in nasal allergy. Int Arch Allergy Appl Immunol
- Terada N, Konno A, Ito E, Sugiyama T, Togawa K. Infiltration and activation of eosinophils during the late phase response in subjects with nasal allergy: From a study of nasal lavage fluid. Jpn J Allergy 1991; 40: 181–90, [in Japanese]
- Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant interleukin‐5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol 1992; 90: 160–8
- Terada N, Konno A, Natori T, Tada H, Togawa K. Interleukin‐5 preferentially recruits eosinophils from vessels in nasal mucosa. Acta Otolaryngol (Stockh) 1993, Suppl 506: 57–60
- Clutterbuck E J., Hirst E M A, Sanderson C J. Human interleukin‐5 (IL‐5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL‐1, IL‐3, IL‐6 and GMCSF. J Exp Med 1988; 167: 219–24
- Lopez A F., Sanderson C J., Gamble J R., Campbell H R., Young I G., Vadas M A. Recombinant human interleukin‐5 is a selective activation of human eosinophil function. J Exp Med 1988; 167: 219–24
- Yamaguchi Y, Hayashi Y, Sugama Y, et al. Highly purified murine interleukin‐5 (IL‐5) stimulates eosinophil function and prolongs in vitro survial. J Exp Med 1988; 167: 1737–42
- Terada N, Konno A, Tada H, Togawa K. The degranulation effect of interleukin‐5 on eosinophils. Pract Otol (Kyoto) 1992, Suppl 57: 52–6, [in Japanese]
- Harriman G R., Kunimoto D Y., Elliott J F., Paetkau V, Strober W. The role of IL‐5 in IgA B cell differentiation. J Immunol 1988; 140: 3033–9
- Beagley K W., Eldridge J H., Kiyono H, Everson P, Koopman W J. Recombinant murine IL‐5 induced high rate synthesis in cycling IgA‐positive Preyer's patch B cells. J Immunol 1989; 141: 2305–12
- Fujisawa T, Abu‐Ghazaleh R, Kita H, Sanderson C J., Gleich G J. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 144: 642–6
- Abu‐Ghazaleh R I., Fujisawa T, Mestecky J, Kyle R A., Gleich G J. IgA‐induced eosinophil degranulation. J Immunol 1989; 142: 2393–400
- Tanabe T, Konishi M, Mizuta T, Noma T, Honjo T. Molecular cloning and structure of the human inter‐leukin‐5 gene. J Biol Chem 1987; 262: 16580–4
- Fukuda Y, Hashino J, Haruyama M, Tsuruoka N, Nakazato H, Nakanishi T. A sandwich enzyme‐linked immunosorbent assay for human interleukin‐5. J Immunol Meth 1991; 143: 89–94
- Okuda M. Fundmental and clinical studies on nasal allergy. Otologica Fukuoka 1974; 20: 297–344, [in Japanese]
- Chirgin J M., Przybyla A E., MacDonald R J., Rutter W J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–9
- Saiki R K., Gelfand D H., Stoffel S, et al. Primer‐directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–91
- Analysis of genomic DNA by Southern hybridization. Molecular cloning, J E. Sambrook, E F. Fritsch, T Maniatis. Cold Spring Harbor Laboratory Press, New York 1989; 9.31–9.62
- Terada N. Changes with time in allergic reactions in nasal mucosa. J Jpn Rhinol 1988; 27: 28–9, [in Japanese]
- Fukuda T, Akutsu I, Amagai M, Numao T, Motojima S, Makino S. Antigen‐induced biphasic eosinophil infiltration in the airways of actively sensitized guinea pigs and its inhibition by PAF antagonist and cyclosporin A. Jpn J Allergol 1990; 39: 548–52, [in Japanese]
- Sutherland G R., Baker E, Callen D F., et al. Interleukin‐5 is at 5q31 and is deleted in the 5q‐syndrome. Blood 1988; 71: 1150–7
- Hamid Q, Azziwi M, Ying S, et al. Expression of mRNA for interleukin‐5 in mucosal biopsies from asthma. J Clin Invest 1991; 87: 1541–6
- Durham S R., Ying S, Varney V A., et al. Cytokine messenger RNA expression for IL‐3, IL‐4, IL‐5 and granulocyte/macrophage‐colony‐stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992; 148: 2390–4
- Desreumaux P, Janin A, Colombel J F., et al. Interleukin‐5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992; 175: 293–6
- Bradding P, Feather I H., Wilson S, et al. Immunolocal‐ization of cytokines in the nasal mucosa of normal and perennial, rhinitic subjects. J Immunol 1993; 151: 3853–65